DMAA Drugs Made In America Acquisition Corp. Ordinary Shares

Financial Services

$10.61+0.09%ClosedMarket Cap: $357.7M

As of 2026-05-26

Valuation

P/E (TTM)

61.55

PEG

—

P/B

1.04

P/S

0.00

EV/EBITDA

-136.01

DCF Value

—

FCF Yield

-0.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

2.9%

ROA

2.8%

ROIC

-1.1%

Income Statement

Periods shown are fiscal year quarters (may differ from calendar year)

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q1 null	$0.00	NaN%	$-143.3K	$2.0M	$—	—
Q4 null	$0.00	NaN%	$-2.1M	$213.0K	$—	—
FY null	$0.00	NaN%	$-2.8M	$5.9M	$—	—
Q3 null	$0.00	NaN%	$-263.7K	$2.2M	$—	—
Q2 null	$0.00	NaN%	$-131.9K	$2.3M	$—	—
Q1 null	$0.00	NaN%	$-330.9K	$1.3M	$—	—
Q4 null	$0.00	NaN%	$-279.00	$-279.00	$—	—
FY null	$0.00	NaN%	$-479.00	$-479.00	$—	—
Q3 null	$0.00	NaN%	$-144.9K	$-144.9K	$—	—
Q2 null	$0.00	NaN%	$-54.93	$-54.93	$—	—